Malin Corporation PLC is focused on investing in life sciences companies. The Company’s assets give investors access to life sciences businesses with exposure across diverse modalities, therapeutic areas and geographies. Its business includes Poseida, Viamet, Xenex, WaveBreak, KNOW Bio, and Artizan. Poseida is a clinical-stage biopharmaceutical company building a pipeline of Chimeric antigen receptor T cell (CAR-T) product candidates. Xenex is a commercial-stage medical device company focused on reducing healthcare-associated infections with its non-mercury, full-spectrum disinfection LightStrike Germ-Zapping robots. KNOW Bio is a life science company engaged in the fields of nitric oxide and precision light therapy. WaveBreak Therapeutics company focuses on the development of medicines for the treatment of protein-misfolding diseases including Alzheimer's and Parkinson's. Artizan is a biotechnology company.